Evaluation of the Transitional and Lifelong Care Program
NCT ID: NCT05849285
Last Updated: 2024-04-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
410 participants
OBSERVATIONAL
2024-01-03
2027-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Injured Spinal Cord Pressure Evaluation
NCT02721615
Monitoring Fatigue In Daily Life In Adults With Cerebral Palsy or Acquired Brain Injury
NCT07135791
Coaching for Caregivers of Children With Spinal Cord Injury
NCT03898700
Evaluation of a Bowel and Bladder Health Management Program for Individuals With Spinal Cord Injury (SCI)
NCT01920243
Feasibility Clinical Study of NLA Tool-US
NCT01995682
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
TLC Patient
Patients of the TLC program with CP/SB/DD
TLC Clinic
Patients of the TLC clinic - receive coordinated multidisciplinary and specialized care from a team
Control Patient
Adults with CP/SB/DD that are not patients of the TLC Program
No interventions assigned to this group
TLC Caregiver
Caregiver of Patients of the TLC program with CP/SB/DD
TLC Clinic
Patients of the TLC clinic - receive coordinated multidisciplinary and specialized care from a team
Control Caregiver
Caregiver of Adults with CP/SB/DD that are not patients of the TLC Program
No interventions assigned to this group
Healthcare Providers
Healthcare Providers who care for patients in the TLC clinic
TLC Clinic
Patients of the TLC clinic - receive coordinated multidisciplinary and specialized care from a team
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
TLC Clinic
Patients of the TLC clinic - receive coordinated multidisciplinary and specialized care from a team
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2\. Patient participants will have continuously resided in Ontario during the years of 2015 to 2020 to facilitate full data retrieval from the administrative dataset.
3\. Healthcare providers, of any discipline, who provide care to adults with childhood-onset conditions in the TLC program.
Exclusion Criteria
21 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Western University, Canada
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Laura Brunton
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Laura K Brunton, PhD
Role: PRINCIPAL_INVESTIGATOR
Western University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Parkwood Institute
London, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
184575
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
122419
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.